1-3 of 3
Anjana Elefante, Pharm, D
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BCL-2 Expression at the Time of Diagnosis Affects the Clinical Outcome of Patients with Germinal Center and Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Chemo-Immunotherpy

Sulada Pukiat, MD, Nuttapong Ngamphaiboon, MD, Pooja Advani, MBBS, Julio Chavez, MD, George Deeb, MD, Anjana Elefante, Pharm, D, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2010) 116 (21): 3130.
https://doi.org/10.1182/blood.V116.21.3130.3130
Published: 2010
Journal Articles

The Expression of Bcl-6 In Diffuse Large B Cell Lymphoma (DLBCL) Is Associated with Improved Progression Free Survival and Overall Survival Following Front-Line Rituximab-Chemotherapy

Pooja Advani, MBBS, Nuttapong Ngamphaiboon, MD, Sulada Pukiat, MD, Julio Chavez, MD, George Deeb, MD, Anjana Elefante, Pharm, D, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2010) 116 (21): 5073.
https://doi.org/10.1182/blood.V116.21.5073.5073
Published: 2010
Journal Articles

Classification of Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) According to the Han's Criteria Defines Two Groups of Patients with Different Clinical Outcomes Following Systemic Rituximab-Multi Agent Anthracycline-Based Therapy.

Julio Chavez, MD, Mark Walsh, Pharm, D, Francisco J Hernandez-Ilizaliturri, MD, Anjana Elefante, Pharm, D, Myron S. Czuczman, MD
Journal: Blood
Blood (2009) 114 (22): 623.
https://doi.org/10.1182/blood.V114.22.623.623
Published: 2009